Elevated circulating cell-free mitochondrial DNA level in cerebrospinal fluid of narcolepsy type 1
Brain Communications · 04.03.2025 · 7 (2)
DOI: 10.1093/braincomms/fcaf125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Communications, online erschienen am 17.04.2025. Verfasst von Monica Moresco und 10 weiteren Autor:innen. Beteiligte Einrichtung: Programma di Neurogenetica, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna 40139, Italy. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Ministry of Health.
Abstract (Originalsprache)
Narcolepsy type 1 (NT1) is a rare neurological disorder characterized by excessive daytime sleepiness and cataplexy, thought to result from an autoimmune process targeting the hypothalamic hypocretin-producing neurons. Aiming to add clues to the latter hypothesis, we investigated circulating cell-free mitochondrial DNA (ccf-mtDNA) levels in cerebrospinal fluid (CSF), a possible biomarker for neurodegeneration, neuroinflammation or immune activation, from 46 NT1 patients with low CSF hypocretin-1, compared with 32 controls. We found significantly increased ccf-mtDNA levels in NT1 patients compared with controls, which negatively correlated with CSF hypocretin-1 concentrations. Additionally, higher ccf-mtDNA levels were observed in patients with elevated number of sleep onset rapid eye movement periods. These observations imply that increased levels of ccf-mtDNA associate with reduced CSF hypocretin-1 concentrations leading to greater alteration in sleep architecture. Furthermore, cytokine profiling in CSF revealed significant changes in interleukins 6 and 18 in NT1 patients, suggesting an active neuroinflammatory process possibly linked to ccf-mtDNA release, thus pointing to a specific inflammatory signature in NT1. These findings hint a potential mitochondrial dysfunction and neuroinflammation in NT1. Further studies are needed to elucidate the underlying mechanisms and how this may reflect on therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Programma di Neurogenetica, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna 40139, Italy.
- UOC Clinica Neurologica, IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna 40139, Italy.
- Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna 40126, Italy.
- Stanford Center for Sleep Sciences and Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.
- Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena 42121, Italy.
ORCID-Profile: Monica Moresco, Concetta Valentina Tropeano, Martina Romagnoli, Emmanuel Mignot, Alessandra Maresca
Förderung
- Italian Ministry of Health
Zitieren
APA
Moresco, M., Tropeano, C. V., Romagnoli, M., Neccia, G., Rapone, A., Pizza, F., Vandi, S., Mignot, E., Maresca, A., Carelli, V., & Plazzi, G. (2025). Elevated circulating cell-free mitochondrial DNA level in cerebrospinal fluid of narcolepsy type 1. Brain Communications, 7(2). https://doi.org/10.1093/braincomms/fcaf125
Vancouver
Moresco M, Tropeano CV, Romagnoli M, Neccia G, Rapone A, Pizza F, et al. Elevated circulating cell-free mitochondrial DNA level in cerebrospinal fluid of narcolepsy type 1. Brain Communications. 2025;7(2). doi:10.1093/braincomms/fcaf125
BibTeX
@article{Moresco2025,
author = {Moresco, Monica and Tropeano, Concetta Valentina and Romagnoli, Martina and Neccia, Giulia and Rapone, Alessandro and Pizza, Fabio and Vandi, Stefano and Mignot, Emmanuel and Maresca, Alessandra and Carelli, Valerio and Plazzi, Giuseppe},
title = {Elevated circulating cell-free mitochondrial DNA level in cerebrospinal fluid of narcolepsy type 1},
journal = {Brain Communications},
year = {2025},
volume = {7},
number = {2},
doi = {10.1093/braincomms/fcaf125}
}
EUVIMED